QUCY
Mainz Biomed N.V.
NASDAQ: QUCY · HEALTHCARE · DIAGNOSTICS & RESEARCH
$0.43
-6.65% today
Updated 2026-04-30
Market cap
$6.28M
P/E ratio
—
P/S ratio
11.69x
EPS (TTM)
$-2.70
Dividend yield
—
52W range
$0 – $1
Volume
0.8M
Mainz Biomed N.V. (QUCY) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-2,160.00%
ROE
-488.30%
ROA
-89.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | $577348.00 | $-11.69M | 30.77% | -1,684.36% | -2,024.79% |
| 2022 | $529877.00 | $-26.39M | 34.38% | -4,990.60% | -4,979.90% |
| 2023 | $895479.00 | $-26.30M | 56.91% | -2,975.47% | -2,936.50% |
| 2024 | $893991.00 | $-21.65M | 64.31% | -2,091.23% | -2,421.80% |
| 2025 | $537080.00 | $-16.21M | 72.58% | -2,414.04% | -3,018.31% |